Cargando…
Hepatitis C eradication with sofosbuvir leads to significant metabolic changes
AIM: To assess the effect of sofosbuvir (SOF) based regimens on glycemic and lipid control. METHODS: This is a retrospective analysis of hepatitis C virus (HCV)-infected patients treated and cured with a SOF regimen [SOF/ribavirin/interferon, SOF/simeprevir, or SOF/ledipasvir (LDV) ± ribavirin] from...
Autores principales: | Morales, Amilcar L, Junga, Zachary, Singla, Manish B, Sjogren, Maria, Torres, Dawn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5165269/ https://www.ncbi.nlm.nih.gov/pubmed/28050236 http://dx.doi.org/10.4254/wjh.v8.i35.1557 |
Ejemplares similares
-
Safe and effective sofosbuvir-based therapy in patients with mental health disease on hepatitis C virus treatment
por: Tang, Lydia Shuk Yee, et al.
Publicado: (2016) -
Efficacy and safety of sofosbuvir and ledipasvir in Japanese patients aged 75 years or over with hepatitis C genotype 1
por: Ozono, Yoshinori, et al.
Publicado: (2017) -
Safety and efficacy of ledipasvir/sofosbuvir on hepatitis C eradication in hepatitis C virus/human immunodeficiency virus co-infected patients
por: He, Xiaoping, et al.
Publicado: (2017) -
Dynamics of cytokines predicts risk of hepatocellular carcinoma among chronic hepatitis C patients after viral eradication
por: Lu, Ming-Ying, et al.
Publicado: (2022) -
Tailored eradication vs empirical bismuth-containing quadruple therapy for first-line Helicobacter pylori eradication: A comparative, open trial
por: Choi, Youn I, et al.
Publicado: (2019)